Full Press Release Details
ALPHARETTA, Ga., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced that management will present a corporate update at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference which will be available on demand on Thursday, August 15, 2024, at 7:00 a.m. ET. Victor Chong, MD, MBA, Chief Medical Officer, will also participate in a panel discussion on the Evolving Therapeutic Landscape of AMD.
A link to the live and archived webcast presentation may be accessed on the Clearside website under the Investors section: Events and Presentations.
About Clearside Biomedical, Inc.
Investor and Media Contacts:
Source: Clearside Biomedical, Inc.
Tags
Clearside Biomedical
HC Wainwright Conference